Biotech Startup
Appears in 1 story
Licensed developer of DT-109
Severe fatty liver disease has almost no drugs that reverse it. On July 11, 2026, a University of Michigan team reported that an experimental compound called DT-109 did exactly that in mice and monkeys, by fixing the gut instead of the liver.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
